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OBJECTIVE: Caspase-2 is an initiator caspase involved in multiple apoptotic
pathways, particularly in response to specific intracellular stressors (eg, DNA
damage, ER stress). We recently reported that caspase-2 was pivotal for the
induction of cell death triggered by excessive intracellular accumulation of long-
chain fatty acids, a response known as lipoapoptosis. The liver is particularly
susceptible to lipid-induced damage, explaining the pandemic status of non-
alcoholic fatty liver disease (NAFLD). Progression from NAFLD to non-alcoholic
steatohepatitis (NASH) results, in part, from hepatocyte apoptosis and
consequential paracrine-mediated fibrogenesis. We evaluated the hypothesis that
caspase-2 promotes NASH-related cirrhosis.
DESIGN: Caspase-2 was localised in liver biopsies from patients with NASH. Its
expression was evaluated in different mouse models of NASH, and outcomes of
diet-induced NASH were compared in wild-type (WT) and caspase-2-deficient
mice. Lipotoxicity was modelled in vitro using hepatocytes derived from WT and
caspase-2-deficient mice.
RESULTS: We showed that caspase-2 is integral to the pathogenesis of NASH-
related cirrhosis. Caspase-2 is localised in injured hepatocytes and its expression
was markedly upregulated in patients and animal models of NASH. During
lipotoxic stress, caspase-2 deficiency reduced apoptosis, inhibited induction of
profibrogenic hedgehog target genes in mice and blocked production of hedgehog
ligands in cultured hepatocytes.
CONCLUSIONS: These data point to a critical role for caspase-2 in lipid-induced
hepatocyte apoptosis in vivo for the production of apoptosis-associated fibrogenic
factors and in the progression of lipid-induced liver fibrosis. This raises the
intriguing possibility that caspase-2 may be a promising therapeutic target to
prevent progression to NASH.
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